AAAAAA

   
Results: 1-8 |
Results: 8
CD34-LYMPHOCYTES FROM PBSC HARVESTS USING THE ISOLEX(R) SYSTEM( CELL SELECTION AND SPECIFIC DEPLETION OF CD4 AND CD8 T)
Authors: BROCKMEYER C DREXLER K RAKERS M SCHWENDER J REHBERGER B STADE B SCHUPP R SPAETHE R
Citation: C. Brockmeyer et al., CD34-LYMPHOCYTES FROM PBSC HARVESTS USING THE ISOLEX(R) SYSTEM( CELL SELECTION AND SPECIFIC DEPLETION OF CD4 AND CD8 T), Bone marrow transplantation, 21, 1998, pp. 16-16
EFFICACY OF ANTIBODY TREATMENT WITH 17 1A ON REDUCTION OF MRD AFTER COMPLETION OF HIGH-DOSE CHEMOTHERAPY WITH TRANSPLANTATION OF IN-VITRO TUMOR-CELL PURGED PBSC GRAFTS IN HIGH-RISK BREAST-CANCER PATIENTS/
Authors: HEMPEL D ORUZIO D MULLER P BEHR W BROCKMEYER C WOCHNER M EHNLE S RIETHMULLER G SCHLIMOK G
Citation: D. Hempel et al., EFFICACY OF ANTIBODY TREATMENT WITH 17 1A ON REDUCTION OF MRD AFTER COMPLETION OF HIGH-DOSE CHEMOTHERAPY WITH TRANSPLANTATION OF IN-VITRO TUMOR-CELL PURGED PBSC GRAFTS IN HIGH-RISK BREAST-CANCER PATIENTS/, European journal of cancer, 33, 1997, pp. 674-674
CD34-CELLS RELEASED DURING ISOLEX(TM) SELECTION HAVE MEMBRANE INTEGRITY WITH NO RESIDUAL CELL-SURFACE ANTIBODY( STEM)
Authors: BROCKMEYER C DEANS R SCHWENDER J HING C SPAETHE R TASIAUX N
Citation: C. Brockmeyer et al., CD34-CELLS RELEASED DURING ISOLEX(TM) SELECTION HAVE MEMBRANE INTEGRITY WITH NO RESIDUAL CELL-SURFACE ANTIBODY( STEM), Blood, 88(10), 1996, pp. 3705-3705
IMMUNOMAGNETIC CELL SELECTION FOR REMOVAL AND ENHANCED DETECTION OF MRD FROM PBSC HARVEST IN BREAST-CANCER PATIENTS
Authors: HEMPEL D ORUZIO D BROCKMEYER C WOCHNER M BEHR W EHNLE S SCHLIMOK G
Citation: D. Hempel et al., IMMUNOMAGNETIC CELL SELECTION FOR REMOVAL AND ENHANCED DETECTION OF MRD FROM PBSC HARVEST IN BREAST-CANCER PATIENTS, Blood, 88(10), 1996, pp. 991-991
EX-VIVO B-LYMPHOCYTE AND T-LYMPHOCYTE DEPLETION OF PARTIALLY INCOMPATIBLE MARROW GRAFT
Authors: CAVAZZANACALVO M JABADO N HADDAD E BENSUSSAN D BROCKMEYER C FISCHER A
Citation: M. Cavazzanacalvo et al., EX-VIVO B-LYMPHOCYTE AND T-LYMPHOCYTE DEPLETION OF PARTIALLY INCOMPATIBLE MARROW GRAFT, Blood, 88(10), 1996, pp. 1668-1668
IMMUNOMAGNETIC REMOVAL OF TUMOR-CELLS USING MONOCLONAL-ANTIBODIES AGAINST B-CELL EPITOPES OR TUMOR-ASSOCIATED BREAST-CANCER ANTIGENS
Authors: BROCKMEYER C ZUBEK EM LINGNAU A SCHWENDER J SPAETHE R
Citation: C. Brockmeyer et al., IMMUNOMAGNETIC REMOVAL OF TUMOR-CELLS USING MONOCLONAL-ANTIBODIES AGAINST B-CELL EPITOPES OR TUMOR-ASSOCIATED BREAST-CANCER ANTIGENS, European journal of cancer, 31A, 1995, pp. 65-65
A CLINICAL-SYSTEM FOR IMMUNOMAGNETIC REMOVAL OF BREAST-CANCER OR LYMPHOMA-CELLS FROM BLOOD OR DONE MARROW MONONUCLEAR-CELLS
Authors: BROCKMEYER C ZUBEK EM LINGNAU A SCHWENDER J SPAETHE R
Citation: C. Brockmeyer et al., A CLINICAL-SYSTEM FOR IMMUNOMAGNETIC REMOVAL OF BREAST-CANCER OR LYMPHOMA-CELLS FROM BLOOD OR DONE MARROW MONONUCLEAR-CELLS, Experimental hematology, 23(8), 1995, pp. 861-861
MONOCLONAL-ANTIBODIES FOR IMMUNOMAGNETIC PURGING
Authors: BROCKMEYER C BOHM W DREXLER K KOLL R SPAETHE R
Citation: C. Brockmeyer et al., MONOCLONAL-ANTIBODIES FOR IMMUNOMAGNETIC PURGING, Experimental hematology, 22(8), 1994, pp. 837-837
Risultati: 1-8 |